TheStreet.com RealMoney

Defensive Stocks Left in the Dust

By Jim Cramer

 About this article:
 Could the defensive stocks be hated more? Could someone sell Genzyme lower? Could someone pound General Mills and Pepsi more? Could someone dislike Coca-Cola despite the weak dollar? Procter & Gamble is so stalled here. Colgate-Palmolive got crushed last week off of what really was a great quarter (biggest weak-dollar play, too). How about the Clorox hit (well described by Gary Morrow to my right)? Abbott Labs is totally toxic to the point that it is brutal to those of us who own the stock. Bristol-Myers Squibb has had so much good news, and nobody cares whatsoever. And I respect this move. I think it is telling and accurate, as I have seen cyclical recoveries, and they can be endless as anyone who traded way back in 1987 before the crash and then again right after. It was like this. You had months and months of...

You have just read the beginning of a premium article from our RealMoney Service. To read the rest of this article and sign up for a FREE trial please click below.

ACCESS STORY & START A FREE 14-Day Trial
Or, call us at 1-866-321-TSCM (8726) Monday-Friday, 8 a.m.-6 p.m. ET.
Outside the U.S. and in Canada, call 1-212-321-5200.



Already a RealMoney subscriber? LOG IN.
Username: Page data is submitted securely.
Password:
Forgot your Password? Click here


100% Money-Back Guarantee
If you decide to subscribe and you're not completely satisfied with TheStreet.com RealMoney, just call us within the first 30 days of your subscription and we'll refund your full annual subscription price — guaranteed.




If you choose a 14-day free trial of RealMoney and you do NOT call to cancel within those 14 days, you will pay $129.95 — a $100 savings off the regular annual subscription price of $229.95. Unless you cancel before the end of that year, your subscription will automatically renew for another year at the then-current subscription price.

Offer applies only to new annual subscriptions, and is subject to change at any time. Void where prohibited.

If you choose a monthly subscription, you pay $34.95 per month. You will be notified if the current monthly rate of $34.95 changes at any time in the future.

TheStreet.com is a publisher. None of the contributors or their affiliates will provide you with personally tailored advice concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. From time to time, any or all of the contributors or their affiliates may hold positions in securities mentioned and they may trade for their own accounts. In cases where the position is held at the time of publication, appropriate disclosure is made.

© TheStreet.com, Inc., 14 Wall Street, 15th Floor, New York, NY 10005.